SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-18-020146
Filing Date
2018-04-27
Accepted
2018-04-27 16:10:15
Documents
5
Period of Report
2018-06-19
Effectiveness Date
2018-04-27

Document Format Files

Seq Description Document Type Size
1 DEF 14A bp09373x1_def14a.htm DEF 14A 831775
2 bp09373x1_proxycard01.jpg GRAPHIC 1316533
3 bp09373x1_proxycard02.jpg GRAPHIC 1086603
4 logo_madrigalpharmaceuticals.jpg GRAPHIC 57892
5 sig_paulafriedman.jpg GRAPHIC 33792
  Complete submission text file 0001140361-18-020146.txt   4032444
Mailing Address 200 BARR HARBOR DRIVE, SUITE 400 WEST CONSHOHOCKEN PA 19428
Business Address 200 BARR HARBOR DRIVE, SUITE 400 WEST CONSHOHOCKEN PA 19428 404-380-9263
MADRIGAL PHARMACEUTICALS, INC. (Filer) CIK: 0001157601 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-33277 | Film No.: 18783939
SIC: 2834 Pharmaceutical Preparations